Pseudomonas aeruginosa and other related species

[1] EARLY BACTERIOLOGICAL, IMMUNOLOGICAL, AND CLINICAL COURSES OF YOUNG INFANTS WITH CYSTIC-FIBROSIS IDENTIFIED BY NEONATAL SCREENING [J]. JOURNAL OF PEDIATRICS, 1991, 119 (02) : 211 - 217

[2] EFFECTS OF HUMAN NEUTROPHIL ELASTASE AND PSEUDOMONAS-AERUGINOSA PROTEINASES ON HUMAN RESPIRATORY EPITHELIUM [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1991, 4 (01) : 26 - 32

[3] ERYTHROMYCIN AND ROXITHROMYCIN POTENTIATE HUMAN NEUTROPHIL LOCOMOTION INVITRO BY INHIBITION OF LEUKOATTRACTANT-ACTIVATED SUPEROXIDE GENERATION AND AUTOOXIDATION [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (05) : 966 - 973

[4] ACUTE AND LONG-TERM AMILORIDE INHALATION IN CYSTIC-FIBROSIS LUNG-DISEASE - A RATIONAL APPROACH TO CYSTIC-FIBROSIS THERAPY [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (03): : 605 - 612

[5] LOWER RESPIRATORY-INFECTION AND INFLAMMATION IN INFANTS WITH NEWLY-DIAGNOSED CYSTIC-FIBROSIS [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6994) : 1571 - 1572

[6] AUERBACH HS, 1985, LANCET, V2, P686

[7] GLYCOSPHINGOLIPID RECEPTORS FOR PSEUDOMONAS-AERUGINOSA [J]. INFECTION AND IMMUNITY, 1990, 58 (07) : 2361 - 2366

[8] PSEUDOMONAS-AERUGINOSA EXOENZYME-S IS AN ADHESIN [J]. INFECTION AND IMMUNITY, 1991, 59 (09) : 2859 - 2863

[9] PULMONARY DISPOSITION OF ANTIMICROBIAL AGENTS - INVIVO OBSERVATIONS AND CLINICAL RELEVANCE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) : 1176 - 1180

[10] IMMUNOHISTOPATHOLOGIC LOCALIZATION OF PSEUDOMONAS-AERUGINOSA IN LUNGS FROM PATIENTS WITH CYSTIC-FIBROSIS - IMPLICATIONS FOR THE PATHOGENESIS OF PROGRESSIVE LUNG DETERIORATION [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (06): : 1650 - 1661

[1] EARLY BACTERIOLOGICAL, IMMUNOLOGICAL, AND CLINICAL COURSES OF YOUNG INFANTS WITH CYSTIC-FIBROSIS IDENTIFIED BY NEONATAL SCREENING [J]. JOURNAL OF PEDIATRICS, 1991, 119 (02) : 211 - 217

[2] EFFECTS OF HUMAN NEUTROPHIL ELASTASE AND PSEUDOMONAS-AERUGINOSA PROTEINASES ON HUMAN RESPIRATORY EPITHELIUM [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1991, 4 (01) : 26 - 32

[3] ERYTHROMYCIN AND ROXITHROMYCIN POTENTIATE HUMAN NEUTROPHIL LOCOMOTION INVITRO BY INHIBITION OF LEUKOATTRACTANT-ACTIVATED SUPEROXIDE GENERATION AND AUTOOXIDATION [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (05) : 966 - 973

[4] ACUTE AND LONG-TERM AMILORIDE INHALATION IN CYSTIC-FIBROSIS LUNG-DISEASE - A RATIONAL APPROACH TO CYSTIC-FIBROSIS THERAPY [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (03): : 605 - 612

[5] LOWER RESPIRATORY-INFECTION AND INFLAMMATION IN INFANTS WITH NEWLY-DIAGNOSED CYSTIC-FIBROSIS [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6994) : 1571 - 1572

[6] AUERBACH HS, 1985, LANCET, V2, P686

[7] GLYCOSPHINGOLIPID RECEPTORS FOR PSEUDOMONAS-AERUGINOSA [J]. INFECTION AND IMMUNITY, 1990, 58 (07) : 2361 - 2366

[8] PSEUDOMONAS-AERUGINOSA EXOENZYME-S IS AN ADHESIN [J]. INFECTION AND IMMUNITY, 1991, 59 (09) : 2859 - 2863

[9] PULMONARY DISPOSITION OF ANTIMICROBIAL AGENTS - INVIVO OBSERVATIONS AND CLINICAL RELEVANCE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) : 1176 - 1180

[10] IMMUNOHISTOPATHOLOGIC LOCALIZATION OF PSEUDOMONAS-AERUGINOSA IN LUNGS FROM PATIENTS WITH CYSTIC-FIBROSIS - IMPLICATIONS FOR THE PATHOGENESIS OF PROGRESSIVE LUNG DETERIORATION [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (06): : 1650 - 1661